Cargando…
Development of Next-Generation Peptide Binders Using In vitro Display Technologies and Their Potential Applications
During the last decade, a variety of monoclonal antibodies have been developed and used as molecular targeting drugs in medical therapies. Although antibody drugs tend to have intense pharmacological activities and negligible side effects, several issues in their development and prescription remain...
Autor principal: | Wada, Akira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730117/ https://www.ncbi.nlm.nih.gov/pubmed/23914189 http://dx.doi.org/10.3389/fimmu.2013.00224 |
Ejemplares similares
-
Next-Generation Sequencing of Antibody Display Repertoires
por: Rouet, Romain, et al.
Publicado: (2018) -
In vitro affinity screening of protein and peptide binders by megavalent bead surface display
por: Diamante, Letizia, et al.
Publicado: (2013) -
PDL1Binder: Identifying programmed cell death ligand 1 binding peptides by incorporating next-generation phage display data and different peptide descriptors
por: He, Bifang, et al.
Publicado: (2022) -
Uses of Next-Generation Sequencing Technologies for the Diagnosis of Primary Immunodeficiencies
por: Seleman, Michael, et al.
Publicado: (2017) -
Integration Technology of Micro-LED for Next-Generation Display
por: Chen, Dingbo, et al.
Publicado: (2023)